20 results
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
8 Jun 22
Current report (foreign)
7:15am
LEADERSHIP IN DERMATOLOGY Innovative Pipeline of Topical Skin Medications SGT-210 Topical ErlotinibKeratoderma & Other Dermatologic Indications SGT
6-K/A
EX-99.1
SLGL
Sol-Gel Technologies Ltd
23 May 22
Notice of Annual Meeting of Shareholders
4:05pm
personnel who will provide leadership for Sol-Gel's success and enhance the Company's shareholders' value, while supporting a performance culture
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
19 May 22
Notice of Annual Meeting of Shareholders
4:30pm
are to attract, motivate and retain highly experienced personnel who will provide leadership for Sol-Gel's success and enhance the Company's shareholders
6-K
EX-99.1
60up s8j5dlukur
16 May 22
Current report (foreign)
7:35am
6-K
EX-99.1
vmkk1 crnegg64wg1
14 Apr 22
Notice of Annual Meeting of Shareholders
4:45pm
6-K
EX-99.1
rxxzh6azn izhep9u9mf
5 Jan 22
Current report (foreign)
9:03am
6-K
EX-99.1
84pz42q
16 Nov 21
Current report (foreign)
4:05pm
6-K
EX-99.1
8xvue 4bx4r
5 Feb 20
Current report (foreign)
3:38pm
6-K
EX-99.1
63hl6c42u3csh3 iy
26 Dec 19
Current report (foreign)
6:03am
6-K
EX-99.2
4fma yc9b3jm
25 Jul 19
Current report (foreign)
6:02am
6-K
EX-99.1
k01rlhyj7bjhyx0
15 Jan 19
Sol-Gel Technologies Appoints John Vieira as U.S. Head of Commercialization
6:33am
20-F
ltf3h9t mse
26 Mar 18
Annual report (foreign)
12:00am
- Prev
- 1
- Next